Fast Digoxin Test System

FDA 510(k) K924504 · Diatron Corp.

Substantially Equivalent

510(k) numberK924504

Submission

Device name
Fast Digoxin Test System
Applicant
Diatron Corp.
San Diego, CA, US
Received
September 4, 1992
Decision date
January 13, 1993
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
KXT – Enzyme Immunoassay, Digoxin
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3320
Specialty
Clinical Toxicology

Other 510(k)s with product code KXT

510(k)DeviceApplicantDecision
K193397ADVIA Centaur® Digoxin assayKXT · Traditional Siemens Healthcare Diagnostics, Inc.07/16/2021SE
K153301Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac IIKXT · Traditional Roche Diagnostics04/08/2016SE
K102346Randox Digoxin AssayKXT · Traditional Randox Laboratories, Ltd.10/14/2011SE
K093441Dimension Vista Loci Digoxin Flex Reagent Cartridge (Digxn), Model K6435KXT · Traditional Siemens Healthcare Diagnostics04/07/2010SE
K082953Architect Idigoxin and Architect Idigoxin Calibrators, Models 1P32-25 and IP32-01KXT · Traditional Biokit, S.A.12/22/2008SE
K061249Axsym Digoxin IIIKXT · Special Abbott Laboratories06/02/2006SE
K033007Bayer Advia Digoxin Assay for the Integrated Module SystemKXT · Traditional Bayer Diagnostics Corp.11/14/2003SE
K023058QMS Digoxin Reagent System on the Abbott Aeroset SystemKXT · Traditional Seradyn10/24/2002SE
K012301Immulite 2000 Digoxin, Models L2KDI2 (200 Tests) and L2KDI6 (600 Tests)KXT · Traditional Diagnostic Products Corp.09/19/2001SE
K011920Emit 2000 Digoxin Assay, Model OSR4H229KXT · Special Syva Co., Dade Behring, Inc.07/02/2001SE

Questions and answers

When was Fast Digoxin Test System cleared by the FDA?

Fast Digoxin Test System (K924504) received a 510(k) decision of Substantially Equivalent on January 13, 1993, 131 days after the submission was received.

What is the product code of K924504?

The FDA product code is KXT – Enzyme Immunoassay, Digoxin, a Class II (moderate risk) device regulated under 21 CFR 862.3320.